Artificial urinary sphincter implantation: focus on iatrogenic complications

Tomilov A1, Veliev E1, Golubtsova E1, Kasyan G1

Research Type

Clinical

Abstract Category

Male Stress Urinary Incontinence (Post Prostatectomy Incontinence)

Abstract 521
Open Discussion ePosters
Scientific Open Discussion Session 105
Friday 19th September 2025
12:55 - 13:00 (ePoster Station 1)
Exhibition
Stress Urinary Incontinence Surgery Retrospective Study Male
1. Botkin Hospital
Presenter
Links

Abstract

Hypothesis / aims of study
Artificial urinary sphincter implantation is the mainstay in the treatment of stress urinary incontinence in men, with thousands of implantations performed each year. Despite the relatively high prevalence of complications, the incidence and risk factors of iatrogenic complications have not been sufficiently investigated. The aim of this study was to investigate iatrogenic complications of AUS implantation.
Study design, materials and methods
We retrospectively reviewed the outcomes of AUS implantation in 67 consecutive male patients from 2004 to 2024 at a single center. Complications were described according to the Clavien-Dindo classification, and iatrogenic complications were counted as well. Risk factors were identified using univariate analysis. A p-value of <0.05 was considered statistically significant.
Results
Median follow-up time was 60.4 months (IQR 11.2-114.0). Twenty-four (35.8%) patients had developed 32 complications: 5 (15.6%) Clavien-Dindo I-II and 27 (84.4%) Clavien-Dindo IIIa-IIIb. Iatrogenic complications were observed in 5 cases (7.5% of all AUS implantations, 15.6% of all complications, and 31.3% of complications requiring revision). Bladder catheterization without prior AUS deactivation was performed in 4 patients, which resulted in cuff erosion. In one patient, an erroneous balloon puncture was performed. The median patient age at development of iatrogenic complication was 77.8 years (IQR 68.7-84.6). All iatrogenic complications required revision. AUS explantation was performed in 3 cases in fragile patients with advanced comorbidities and age more than 77 years. In two cases AUS function was restored, the age of both patients was less than 70 years. The increased risk of iatrogenic complications was noted in case of 3.5 cm cuff use (OR 4.2 (95CI 1.96-11.31), p=0.012)
Interpretation of results
With a median follow-up of more than 5 years, iatrogenic complications occurred in 7.5% of all implantations and about one third of the complications requiring revision. The most frequent iatrogenic complication was cuff erosion. The cause of iatrogenic complications is a lack of understanding of AUS design and functioning by non-urologic medical specialists providing care to patients. In elderly and frail patients, AUS removal is most commonly performed. An increased risk of iatrogenic complications is noted in patients with a 3.5 cuff.
Concluding message
Iatrogenic complications of AUS make up a significant part of the complications requiring revision. Such complications in elderly and frail patients often lead to device loss. The problem of AUS iatrogenic complications requires special attention and close investigation.
Disclosures
Funding no Clinical Trial No Subjects Human Ethics Committee RMACPE Ethics Committee Helsinki Yes Informed Consent Yes
16/07/2025 16:01:31